Search results
Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move...
Zacks via Yahoo Finance· 5 days agoDeciphera Pharmaceuticals (DCPH) possesses the right combination of the two key ingredients for a...
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts
Zacks via Yahoo Finance· 6 days agoThe Large Cap Pharmaceuticals was holding an average PEG ratio of 1.63 at yesterday's closing price....
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Stock: Does It Have More Upside? – Marketing Sentinel
Marketing Sentinel· 7 days agoAmylyx Pharmaceuticals Inc (AMLX) estimates and forecasts Amylyx Pharmaceuticals Inc share prices are performing particularly well not compared to other ...
The Therapeutic Evolution of THC: From Recreational Use to Pharmaceutical Ingredient
Rolling Stone· 5 days agoIn recent years, the perception of tetrahydrocannabinol (THC), the primary psychoactive compound in...
Takeda Pharmaceutical: A Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 6 days agoIn recent months, the company's share price has continued to be in a downward trend due to two key factors. The first is growing concerns among...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 5 days agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap ...
Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know
Zacks via Yahoo Finance· 3 days agoLooking at its valuation, Vertex Pharmaceuticals is holding a Forward P/E ratio of 23.91. For...
Decoding West Pharmaceutical Services Inc (WST): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoThe company's recent focus... Global Demand for Injectable Pharmaceuticals: The rising global demand...
BioMarin Pharmaceutical (BMRN) Tops Q1 Earnings Estimates
Zacks via Yahoo Finance· 4 days agoBioMarin (BMRN) delivered earnings and revenue surprises of 18.33% and 0.14%, respectively, for the...
Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why
Zacks· 5 days agoFree Report) closed at $126.16, marking a -1.93% move from the previous day. This change lagged the S&P 500's daily gain of 0.02%. The drugmaker's stock has dropped by 0.6% in the past month ...